Meningococcal ACWY conjugate vaccine immunogenicity in adolescents with primary or secondary immune deficiencies, a prospective observational cohort study.

GMCs showed a decreasing trend between 3 and 6 to 12 months and between 12 and 24 months postvaccination for all serogroups (Fig. 2 ), albeit not significant for A, W and Y (Supplementary Table 2).

also in 47,180 other papers